Severe community-acquired pneumonia.
Niederman MS, Torres A.
Eur Respir Rev. 2022 Dec 14;31(166):220123. doi: 10.1183/16000617.0123-2022. Print 2022 Dec 31.
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.
REMAP-CAP Investigators; Angus DC.
Intensive Care Med. 2025 Apr;51(4):665-680. doi: 10.1007/s00134-025-07861-w. Epub 2025 Apr 22.
Updates on community acquired pneumonia management in the ICU.
Nair GB, Niederman MS.
Pharmacol Ther. 2021 Jan;217:107663. doi: 10.1016/j.pharmthera.2020.107663. Epub 2020 Aug 15.
[Community-acquired pneumonia].
Seeger A, Rohde G.
Dtsch Med Wochenschr. 2023 Mar;148(6):335-341. doi: 10.1055/a-1940-8944. Epub 2023 Mar 6.
Community-Acquired Pneumonia.
Rider AC, Frazee BW.
Emerg Med Clin North Am. 2018 Nov;36(4):665-683. doi: 10.1016/j.emc.2018.07.001. Epub 2018 Sep 6.
Advancements in the Management of Severe Community-Acquired Pneumonia: A Comprehensive Narrative Review.
Davis D, Thadhani J, Choudhary V, Nausheem R, Vallejo-Zambrano CR, Mohammad Arifuddin B, Ali M, Carson BJ, Kanwal F, Nagarajan L.
Cureus. 2023 Oct 12;15(10):e46893. doi: 10.7759/cureus.46893. eCollection 2023 Oct.
Community-acquired pneumonia: Epidemiology, diagnosis, prognostic severity scales, and new therapeutic options.
Oliveira E Silva PG, Cerqueira Batista Filho LA, Ismael PF, Victoria VES, Alexandre TM, Larissa SM.
Medwave. 2023 Dec 7;23(11):e2719. doi: 10.5867/medwave.2023.11.2719.
Ceftaroline in severe community-acquired pneumonia.
Cilloniz C, Pericàs JM, Rojas J.
Rev Esp Quimioter. 2022 Apr;35 Suppl 1(Suppl 1):28-30. doi: 10.37201/req/s01.06.2022. Epub 2022 Apr 22.
Severe community-acquired pneumonia (sCAP): advances in management and future directions.
Martin-Loeches I, Reyes LF, Rodriguez A.
Thorax. 2025 Jul 15;80(8):565-575. doi: 10.1136/thorax-2024-222296.
Severe community-acquired pneumonia.
Leeper KV Jr.
Semin Respir Infect. 1996 Jun;11(2):96-108.
